3.93
-0.07 (-1.75%)
-0.07 (-1.75%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
Big Cap Pro
Monthly Subscription
for only
|
Small Cap Basic
Monthly Subscription
for only
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
BELLUS Health Inc | BLU | NASDAQ | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded ![]() |
|
---|---|---|---|---|
-0.07 | -1.75% | 3.93 | 15:18:17 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
4.01 | 3.795 | 4.08 | 4.00 |
Bid Price | Ask Price | Spread | News | |
---|---|---|---|---|
3.93 | 3.94 | 0.01 | - | - |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
7,266 | 993,584 | $ 3.90 | $ 3,877,199 | 1,310,535 | 2.01 - 12.03 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:18:16 | 100 | $ 3.93 | USD |
BELLUS Health Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 307.87M | 78.34M | 78.34M | $ 27.39k | $ - | - | -6.30 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | 0.00% | - | - |
BELLUS Health News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BLU Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.42 | 4.42 | 3.33 | 3.79 | 2,040,367 | 0.51 | 14.91% |
1 Month | 3.07 | 4.42 | 2.86 | 3.44 | 1,012,694 | 0.86 | 28.01% |
3 Months | 2.46 | 4.42 | 2.25 | 3.11 | 1,654,796 | 1.47 | 59.76% |
6 Months | 2.78 | 4.42 | 2.01 | 2.81 | 1,450,659 | 1.15 | 41.37% |
1 Year | 8.90 | 12.03 | 2.01 | 3.67 | 1,701,861 | -4.97 | -55.84% |
3 Years | 7.12 | 12.03 | 2.01 | 3.78 | 1,277,080 | -3.19 | -44.8% |
5 Years | 7.12 | 12.03 | 2.01 | 3.78 | 1,277,080 | -3.19 | -44.8% |
BELLUS Health Description
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, development of drug candidates for health solutions. |